Esopageal Cancer Magazine Publishing Limited-02-Page:1

Home

Journal & Articles

Editorial Board

Journal System

2025

Home>Issue

2025 Issue:02 Cover Back Contens

List Style:

PD-1 blockade as a novel treatment for esophageal squamous cell carcinoma: Status and prospects [104-122]

Esophageal cancer (EC) is one of the most prev alent malignancies worldwide, with 604,000 newcas es 544,000 deaths reported in 2020 l1l. In Asia, esophageal squamous cellcarcinoma (ESCC) is the most common histopathological type with extensive intratumo

Viewed(184) Export PDF()

Advanced endoscopic therapies in early esophageal cancer [97-103]

Esophageal cancer (EC) is one of the most aggressive gastrointestinal cancers. It is the 8th most common malignancy worldwide the 6th leading cause of cancer related mortality. The overall 5-year survival rate of esophageal cancer ranges from 15% to 25%

Viewed(153) Export PDF()

Porphyromonas gingivalis detection by RNA in situ technologies: a reliable alternative to immunohistochemistry [87-96]

Porphyromonas gingivalis, a gram-negative an aerobe, has been considered as a keystone pathogen in chronic periodontitis other systemic diseas es [l. Long-term colonization by P. gingivalis disrupts oral microecological homeostasis, influences re shape

Viewed(46) Export PDF()

The treatment of esophageal cancer in China: A review of recent progress [74-86]

Esophageal cancer is one of the most malignant tumors in China with a high incidence poor prognosis. Despite the appropriate outcome was achieved during the past few decades because of the diagnosis treatment at the early stage of disease in the high inc

Viewed(637) Export PDF()

Exosome-based liquid biopsy: Opportunities and challenges for changing patient care of gastrointestinal cancers [59-73]

Uche-Anya E, Anyane-Yeboa A, Berzin TM, Ghassemi M, May FP. Artificial intelligence in gastroenterology hepa

Viewed(585) Export PDF()

Total 10

Go to